veronapharma.com
#2,162,033
Global Rankeez rank — last updated 01 Oct 2026
Better than 97.8% of the 99,976,913 domains we track
Best rank recorded
#1,926,371
2026-08
Worst rank recorded
#2,162,033
2026-10
Tracked since
2026-07
3 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how veronapharma.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #2,832,790 |
| CommonCrawl (hyperlink graph) | #6,872,424 |
See how these sources are combined and cross-validated →
Ranking history
veronapharma.com's rank across 3 monthly snapshots. ▼ dropped by 38,136 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #2,123,897 |
| 2026-08 | #1,926,371 |
| 2026-10 | #2,162,033 |
JSON API
{
"veronapharma.com": 2162033,
"history": {
"2026-07": 2123897,
"2026-08": 1926371,
"2026-10": 2162033
}
}
GET https://rankeez.com/api/veronapharma.com.json · see API docs →
More about veronapharma.com
veronapharma.com — page content & similar sites →
Verona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news
veronapharma.com — full site profile →
WHOIS, tech stack and extended traffic history for veronapharma.com.